Patrick McCall - 15 Feb 2022 Form 4 Insider Report for IN8BIO, INC. (INAB)

Reporting relationship: Chief Financial Officer
Issuer ticker: INAB
Reported as of: 15 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Feb 2022, 15:41:27 UTC
Prior SEC filing: 29 Jul 2021
Next SEC filing: 18 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Jason Minio, Attorney-in-Fact

Key filing fact

Patrick McCall filed Form 4 for IN8BIO, INC. (INAB) on 17 Feb 2022.

Key facts

This page summarizes Patrick McCall's Form 4 filing for IN8BIO, INC. (INAB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Feb 2022, 15:41.

Change

Previous filing in this sequence was filed on 29 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INAB transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +84,500
Change %
Price: $0.000000
Shares after: 84,500
Date: 15 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 84,500
Exercise price: $4.28
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.